Mapping Uncertainties in the Upstream: The Case of PLGA Nanoparticles in Salmon Vaccines
暂无分享,去创建一个
Anne Ingeborg Myhr | Kåre Nolde Nielsen | Børge Nilsen Fredriksen | K. N. Nielsen | A. Myhr | B. N. Fredriksen
[1] Yongan Zhang,et al. B lymphocytes from early vertebrates have potent phagocytic and microbicidal abilities , 2006, Nature Immunology.
[2] Nobutaka Ono,et al. Vaccination-Induced Systemic Autoimmunity in Farmed Atlantic Salmon , 2008, The Journal of Immunology.
[3] Kamilla Lein Kjølberg,et al. The notion of ‘responsible development’ in new approaches to governance of nanosciences and nanotechnologies , 2010 .
[4] Risto Karinen,et al. Toward Anticipatory Governance: The Experience with Nanotechnology , 2009 .
[5] Eivind Stø,et al. Who should be precautionary? Governance of nanotechnology in the risk society , 2008, Technol. Anal. Strateg. Manag..
[6] Juan Yu,et al. Poly(lactic-co-glycolic acid) nanoparticles as candidate DNA vaccine carrier for oral immunization of Japanese flounder (Paralichthys olivaceus) against lymphocystis disease virus. , 2011, Fish & shellfish immunology.
[7] T Yashiki,et al. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. , 1988, Chemical & pharmaceutical bulletin.
[8] W. D. de Jong,et al. Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.
[9] A. Ellis. Immunization with bacterial antigens: furunculosis. , 1997, Developments in biological standardization.
[10] Elizabeth A. Casman,et al. Elicitation of Expert Judgments of Uncertainty in the Risk Assessment of Herbicide‐Tolerant Oilseed Crops , 2004, Risk analysis : an official publication of the Society for Risk Analysis.
[11] S. Funtowicz,et al. Science for the PostNormal Age , 2001 .
[12] Jeffrey A. Hubbell,et al. Materials engineering for immunomodulation , 2009, Nature.
[13] Frøydis Gillund,et al. Do uncertainty analyses reveal uncertainties? Using the introduction of DNA vaccines to aquaculture as a case. , 2008, The Science of the total environment.
[14] Matthias Kaiser,et al. Diagnosing and prioritizing uncertainties according to their relevance for policy: the case of transgene silencing. , 2008, The Science of the total environment.
[15] Warren E. Walker,et al. Defining Uncertainty: A Conceptual Basis for Uncertainty Management in Model-Based Decision Support , 2003 .
[16] C. M. Agrawal,et al. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. , 1996, Biomaterials.
[17] B. K. Mishra,et al. Parenteral immunization of fish, Labeo rohita with Poly D, L-lactide-co-glycolic acid (PLGA) encapsulated antigen microparticles promotes innate and adaptive immune responses. , 2010, Fish & shellfish immunology.
[18] M. Birmingham,et al. Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. , 2008, The Journal of infectious diseases.
[19] Mohammad K. Hassan,et al. Hydrolytic degradation of poly(d,l-lactide) as a function of end group: Carboxylic acid vs. hydroxyl , 2006 .
[20] Matthew Kearnes,et al. Nanotechnology, Governance, and Public Deliberation: What Role for the Social Sciences? , 2005 .
[21] P. Midtlyng,et al. Protection, immune responses and side effects in Atlantic salmon (Salmo salarL.) vaccinated against furunculosis by different procedures , 1996 .
[22] Jennifer Kuzma,et al. Upstream Oversight Assessment for Agrifood Nanotechnology: A Case Studies Approach , 2008, Risk analysis : an official publication of the Society for Risk Analysis.
[23] J. Kuzma. Nanotechnology in animal production—Upstream assessment of applications , 2010 .
[24] Anders Baun,et al. The known unknowns of nanomaterials: Describing and characterizing uncertainty within environmental, health and safety risks , 2009 .
[25] Anderson,et al. Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.
[26] R. Sparks,et al. Hydrolytic Degradation of Poly DL-(Lactide) , 1981 .
[27] J. Kappler,et al. Immune mechanisms of protection: can adjuvants rise to the challenge? , 2010, BMC Biology.
[28] H. Weller,et al. Microencapsulation of inorganic nanocrystals into PLGA microsphere vaccines enables their intracellular localization in dendritic cells by electron and fluorescence microscopy. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[29] J. Harris,et al. Oral immunization of rainbow trout with antigen microencapsulated in poly(DL-lactide-co-glycolide) microparticles. , 1997, Vaccine.
[30] G. K. Rosendal,et al. Sustainable Aquaculture: Are We Getting There? Ethical Perspectives on Salmon Farming , 2011 .
[31] M. Dobrovolskaia,et al. Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.
[32] Rassoul Dinarvand,et al. PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution. , 2008, International journal of pharmaceutics.
[33] A. Lillehaug,et al. Recent developments in fish vaccinology. , 1999, Veterinary immunology and immunopathology.
[34] Praveen Elamanchili,et al. Biodegradable Nanoparticle Mediated Antigen Delivery to Human Cord Blood Derived Dendritic Cells for Induction of Primary T Cell Responses , 2003, Journal of drug targeting.
[35] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[36] Jayanth Panyam,et al. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[37] Anthony D Whetton,et al. THOC5/FMIP, an mRNA export TREX complex protein, is essential for hematopoietic primitive cell survival in vivo , 2010, BMC Biology.
[38] D. Lewis,et al. Poly(DL-lactide-co-glycolide)/norethisterone microcapsules: an injectable biodegradable contraceptive. , 1983, Biology of reproduction.
[39] K. Avgoustakis,et al. Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. , 2003, International journal of pharmaceutics.
[40] M. Lynch,et al. The handbook of science and technology studies , 2008 .
[41] Juan Yu,et al. The formulation and immunisation of oral poly(DL-lactide-co-glycolide) microcapsules containing a plasmid vaccine against lymphocystis disease virus in Japanese flounder (Paralichthys olivaceus). , 2008, International immunopharmacology.
[42] A. Jestin,et al. Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection. , 2010, Vaccine.
[43] F. Wickson,et al. Treating Nanoparticles with Precaution: Recognising Qualitative Uncertainty in Scientific Risk Assessment , 2010, Nano Meets Macro.
[44] K. Rock,et al. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. Yewdell,et al. Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design. , 2005, Annual review of immunology.
[46] D. Traver,et al. Identification of dendritic antigen-presenting cells in the zebrafish , 2010, Proceedings of the National Academy of Sciences.
[47] H. Mikkelsen,et al. Immunocompetence and duration of immunity againstVibrio salmonicidaandAeromonas salmonicidaafter vaccination of Atlantic salmon (Salmo salarL.) at low and high temperatures , 1997 .
[48] D. Busch,et al. TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. , 2008, Vaccine.
[49] I. Sommerset,et al. Vaccines for fish in aquaculture , 2005, Expert review of vaccines.
[50] Anne Ingeborg Myhr,et al. Treating Nanoparticles with Precaution: Recognising Qualitative Uncertainty in Scientific Risk Assessment , 2010 .
[51] Ross R. Muth,et al. Biodegradable polymers for use in surgery—polyglycolic/poly(actic acid) homo- and copolymers: 1 , 1979 .
[52] P. Midtlyng. Progress in fish vaccinology , 2005 .
[53] Ø. Evensen,et al. Sequential study of antigen persistence and concomitant inflammatory reactions relative to side-effects and growth of Atlantic salmon (Salmo salar L.) following intraperitoneal injection with oil-adjuvanted vaccines. , 2004, Fish & shellfish immunology.
[54] O. Papadopoulos,et al. Safe use of vaccines and vaccine compliance with food safety requirements. , 2007, Revue scientifique et technique.
[55] C. Gamazo,et al. Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin , 2006, Journal of microencapsulation.
[56] H. L. Leira,et al. Operator safety during injection vaccination of fish. , 1997, Developments in biological standardization.
[57] Ø. Evensen,et al. Bacterial vaccines for fish--an update of the current situation worldwide. , 2005, Developments in biologicals.
[58] Steffen Foss Hansen,et al. Environmental challenges for nanomedicine. , 2008, Nanomedicine.
[59] Peter H Lin,et al. Current advances in research and clinical applications of PLGA-based nanotechnology , 2009, Expert review of molecular diagnostics.
[60] R. Halliwell,et al. The role of basophils in the immunopathogenesis of hypersensitivity to fleas (Ctenocephalides felis) in dogs. , 1987, Veterinary immunology and immunopathology.
[61] A. Ellis,et al. The uptake of human gamma globulin incorporated into poly (D,L-lactide-co-glycolide) microparticles following oral intubation in Atlantic salmon,Salmo salarL. , 1996 .
[62] P J Regan,et al. Fish vaccine injection injuries of the hand. , 2005, British journal of plastic surgery.
[63] J. Heeney,et al. Viruses as vaccine vectors for infectious diseases and cancer , 2010, Nature Reviews Microbiology.
[64] S. Hamdy,et al. “Pathogen-Mimicking” Nanoparticles for Vaccine Delivery to Dendritic Cells , 2007, Journal of immunotherapy.
[65] Nathalie Tufenkji,et al. Aggregation and deposition of engineered nanomaterials in aquatic environments: role of physicochemical interactions. , 2010, Environmental science & technology.
[66] Yi Yan Yang,et al. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. , 2001, Biomaterials.
[67] W. Saltzman,et al. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. , 2009, Biomaterials.
[68] S. Venkatraman,et al. The effect of process variables on the morphology and release characteristics of protein-loaded PLGA particles , 2006 .
[69] K. N. Nielsen,et al. Centre and Periphery of Nano—A Norwegian Context , 2011, Nanoethics.
[70] Virginia Murray. The Precautionary Principle in the 20th Century—Late Lessons from Early Warnings , 2004 .
[71] Helge Toutenburg,et al. The Social Control of Technology , 1982 .